Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 104

1.

Vascular complications associated with use of HIV protease inhibitors.

Gallet B, Pulik M, Genet P, Chedin P, Hiltgen M.

Lancet. 1998 Jun 27;351(9120):1958-9. No abstract available.

PMID:
9654285
[PubMed - indexed for MEDLINE]
2.

Vascular complications associated with use of HIV protease inhibitors.

Vittecoq D, Escaut L, Monsuez JJ.

Lancet. 1998 Jun 27;351(9120):1959. No abstract available.

PMID:
9654286
[PubMed - indexed for MEDLINE]
3.

Vascular complications associated with use of HIV protease inhibitors.

Laurence J.

Lancet. 1998 Jun 27;351(9120):1960. No abstract available.

PMID:
9654287
[PubMed - indexed for MEDLINE]
4.

Lipid lowering therapy in patients with HIV infection.

McBride M, Chin MT, Lee SM, Kelly B.

Lancet. 1998 Nov 28;352(9142):1782-3. No abstract available.

PMID:
9848377
[PubMed - indexed for MEDLINE]
5.

Severe premature coronary artery disease with protease inhibitors.

Henry K, Melroe H, Huebsch J, Hermundson J, Levine C, Swensen L, Daley J.

Lancet. 1998 May 2;351(9112):1328. No abstract available.

PMID:
9643798
[PubMed - indexed for MEDLINE]
6.

Trends in rates of myocardial infarction among patients with HIV.

Holmberg SD, Moorman AC, Greenberg AE.

N Engl J Med. 2004 Feb 12;350(7):730-2; author reply 730-2. No abstract available.

PMID:
14960752
[PubMed - indexed for MEDLINE]
Free Article
7.

Increasing morbidity from myocardial infarction during HIV protease inhibitor treatment?

Jütte A, Schwenk A, Franzen C, Römer K, Diet F, Diehl V, Fätkenheuer G, Salzberger B.

AIDS. 1999 Sep 10;13(13):1796-7. No abstract available.

PMID:
10509592
[PubMed - indexed for MEDLINE]
8.

[Myocardial infarction in the course of antiretroviral therapy with protease inhibitor].

Buccoliero G, Lonero G, Rollo MA, Cristiano L, Romanelli C, Loperfido P, Chimienti A, Angelini P, Resta F.

Recenti Prog Med. 2003 Jun;94(6):264-6. Italian.

PMID:
12793098
[PubMed - indexed for MEDLINE]
9.

Antiretroviral drugs and the risk of myocardial infarction.

Zangerle R, Sarcletti M.

N Engl J Med. 2007 Aug 16;357(7):715-6; author reply 716-7. No abstract available.

PMID:
17703532
[PubMed - indexed for MEDLINE]
10.

C-Reactive protein levels over time and cardiovascular risk in HIV-infected individuals suppressed on an indinavir-based regimen: AIDS Clinical Trials Group 5056s.

Henry K, Kitch D, Dube M, Zackin R, Parker RA, Sprecher D, Hammer S, Currier J; Adult AIDS Clinical Trials Group.

AIDS. 2004 Dec 3;18(18):2434-7. No abstract available.

PMID:
15622323
[PubMed - indexed for MEDLINE]
11.

"Buffalo hump" in HIV-1 infection.

Stocker DN, Meier PJ, Stoller R, Fattinger KE.

Lancet. 1998 Jul 25;352(9124):320-1. No abstract available.

PMID:
9690434
[PubMed - indexed for MEDLINE]
12.

Left main coronary artery disease in a 40-year-old man receiving HIV protease inhibitors.

Hayes P, Muller D, Kuchar D.

Aust N Z J Med. 2000 Feb;30(1):92-3. No abstract available.

PMID:
10800890
[PubMed - indexed for MEDLINE]
13.

Stent implantation for acute left main coronary artery occlusion in an HIV-infected patient on protease inhibitors.

Boccara F, Teiger E, Cohen A.

J Invasive Cardiol. 2002 Jun;14(6):343-6.

PMID:
12042630
[PubMed - indexed for MEDLINE]
14.

[Myocardial infarct with protease inhibitors: a case report].

Lardeur JY, Remblier C, Viel S, Raud-Raynier P, Sosner P, Walter M, Baudier D, Perault-Pochat MC.

Therapie. 2002 May-Jun;57(3):311-3. French. No abstract available.

PMID:
12422549
[PubMed - indexed for MEDLINE]
15.

Coronary heart disease associated with the use of human immunodeficiency virus (HIV)-1 protease inhibitors: report of four cases and review.

Duong M, Buisson M, Cottin Y, Piroth L, Lhuillier I, Grappin M, Chavanet P, Wolff JE, Portier H.

Clin Cardiol. 2001 Oct;24(10):690-4. Review.

PMID:
11594416
[PubMed - indexed for MEDLINE]
16.

Metabolic disorders and cardiovascular risk in HIV-infected patients treated with antiretroviral agents.

Fantoni M, Del Borgo C, Autore C, Barbaro G.

Ital Heart J. 2002 May;3(5):294-9. Review.

PMID:
12066561
[PubMed - indexed for MEDLINE]
17.

Vascular complications associated with use of HIV protease inhibitors.

Behrens G, Schmidt H, Meyer D, Stoll M, Schmidt RE.

Lancet. 1998 Jun 27;351(9120):1958. No abstract available.

PMID:
9654284
[PubMed - indexed for MEDLINE]
18.

Efficacy and tolerability of pravastatin for the treatment of HIV-1 protease inhibitor-associated hyperlipidaemia: a pilot study.

Baldini F, Di Giambenedetto S, Cingolani A, Murri R, Ammassari A, De Luca A.

AIDS. 2000 Jul 28;14(11):1660-2. No abstract available.

PMID:
10983656
[PubMed - indexed for MEDLINE]
19.

Antiretroviral drugs and the risk of myocardial infarction.

Kaplan RC, Tien PC, Lazar J.

N Engl J Med. 2007 Aug 16;357(7):715; author reply 716-7. No abstract available.

PMID:
17699825
[PubMed - indexed for MEDLINE]
Free Article
20.

Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors.

Behrens G, Dejam A, Schmidt H, Balks HJ, Brabant G, Körner T, Stoll M, Schmidt RE.

AIDS. 1999 Jul 9;13(10):F63-70.

PMID:
10416516
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk